Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tract

Gynecologic Oncology

Volumn 42, Issue 3, 1991, Pages 256-264

  van Dam, Peter A ^a   Lowe, David G ^a   Watson, James V ^a   James, Matthew ^a   Chard, Tim ^b   Hudson, Chris N ^a   Shepherd, John H ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN;

ANEUPLOIDY; ANTIGEN EXPRESSION; ARTICLE; CANCER TISSUE; CARCINOGENESIS; CELL CYCLE S PHASE; CONTROLLED STUDY; DIPLOIDY; FEMALE; FEMALE GENITAL TRACT CANCER; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MENSTRUAL CYCLE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; STAINING;

CARCINOMA; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENITAL NEOPLASMS, FEMALE; GENITALIA, FEMALE; HUMAN; IMMUNOCHEMISTRY; MENOPAUSE; PLOIDIES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T;

EID: 0025951005     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/0090-8258(91)90355-9     Document Type: Article

References (60)

1. The origins of human cancer: Molecular mechanisms of carcinogenesis and their implication for cancer prevention and treatment—27th GHA Clowes Memorial Award Lecture
2. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts
3. Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas
4. A novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line
5. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor
6. The neu (c-erbB-2) oncogene
7. Epidermal growth factor and its receptor
8. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells
9. Increased epidermal growth factor receptors on human squamous carcinoma cell lines
10. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumour cell lines by different molecular mechanisms
11. Ligand activation of overexpressed EGF-receptors transforming NIH-3T3 cells
12. The c-erbB-2 gene and its expression in human tumours
13. c-erbB-2 oncoprotein expression in primary human tumors
14. Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues
15. Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma
16. Expression of epidermal growth factor receptor in normal colorectal mucosa adenoma and carcinoma
17. EGFR in human bladder cancer: Comparison of invasive and superficial tumours
18. Epidermal growth factor receptor status as predictor of early recurrence of death from breast cancer
19. Human breast cancer: Correlation of relapse and survival with subamplification of the HER-2/neu oncogene
20. Epidermal growth factor receptor in non-small cell lung cancer
21. Expression of EGFR in human gastric and colonic carcinomas
22. Expression of c-erbB-2 oncoprotein: A prognostic indicator in human breast cancer
23. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer
24. Growth factors and oncogenes in breast cancer
25. Growth factors and oncogenes in human gastrointestinal carcinomas
26. The epidermal growth factor receptor and the prognosis in bladder cancer
27. Multiparameter flow cytometric quantitation of membrane proteins in long-term cryopreserved solid tumours
28. Revised FIGO staging for gynaecological cancer
29. The production and characterisation of monoclonal antibodies to myc, c-erbB-2 and EGF-receptor
30. A monoclonal antibody to the human epidermal growth factor receptor
31. Tissue preparation for simultaneous flow cytometric quantitation of tumour associated antigens and DNA in solid tumours
32. Dual laser beam focusing for flow cytometry through a single crossed cylindrical lens pair
33. Data compression: 8-dimensional flow cytometric data processing with 28 K addressable computer memory
34. Oncogene expression in ovarian cancer: A pilot study of c-myc oncoprotein in serous papillary ovarian cancer
35. Multiparameter flow cytometric quantitation of the expression of the tumor associated antigen SM3 in normal and neoplastic ovarian tissues. A comparison with HMFG1 and HMFG2
36. Clinical significance of abnormal nuclear DNA content in serous ovarian tumors
37. A pragmatic approach to the analysis of DNA histograms with a definable G1 peak
38. Analysis of c-erbB-2 protein expression in conjunction with DNA content using multiparameter flow cytometry
39. Molecular calibration in flow cytometry with sub-attogram detection limit
40. Quantitation of oncogene products by computer-assisted image analysis and flow cytometry
41. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer
42. Epidermal growth factor receptor expression in normal and malignant endometrium
43. Expression of epidermal growth factor receptor and HER-2/Neu in normal and neoplastic cervix, vulva, and vagina
44. Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease
45. Immunohistochemical localisation of the epidermal growth factor receptor in normal human tissues
46. Distribution of neu (c-erbB-2) protein in human skin
47. C-erbB-2 gene product, a membrane protein commonly expressed on human fetal epithelial cells
48. Epidermal growth factor receptor expression in human fetal tissues is age-dependent
49. Pattern of expression of c-erbB-2 oncoprotein in human fetuses
50. Neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues
51. Cyclic changes in epidermal growth factor receptor in human endometrium during menstrual cycle
52. Expression of epidermal growth factor receptors on human cervical, ovarian and vulval carcinomas
53. Specificity of proto-oncogene amplification in human malignant disease
54. Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the cervix
55. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance
56. The expression of ras oncogene product and EGFR in cervical squamous cell carcinoma and its relationship to lymph node involvement
57. Epidermal growth factor receptors in human breast and endometrial carcinomas
58. Occurrence of epidermal growth factor receptors (EGFR) in human adnexal tumors and their prognostic value in advanced ovarian carcinomas
59. Oncogene expression in vivo by ovarian adenocarcinoma and mixed mullarian tumours
60. Protooncogen amplification and tumor ploidy in human ovarian neoplasms